Search Results - "Alvarez, Marcus A."

TGF-β Alters the Proportion of Infiltrating Immune Cells in a Pancreatic Ductal Adenocarcinoma by Trebska-McGowan, Kasia, Chaib, Mehdi, Alvarez, Marcus A., Kansal, Rita, Pingili, Ajeeth K., Shibata, David, Makowski, Liza, Glazer, Evan S.

“…Purpose Immunotherapy, such as checkpoint inhibitors against anti-programmed death-ligand 1 (PD-L1), has not been successful in treating patients with…”
Get full text

TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma by Alvarez, Marcus A., Freitas, Júlia Pedó, Mazher Hussain, S., Glazer, Evan S.

“…Background Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancerrelated mortality in the USA, and the overall incidence of the disease…”
Get full text

Traveling for Pancreatic Cancer Care Is Worth the Trip by Alvarez, Marcus A, Anderson, Kiyah, Deneve, Jeremiah L, Dickson, Paxton V, Yakoub, Danny, Fleming, Martin D, Chinthala, Lokesh K, Zareie, Parya, Davis, Robert L, Shibata, David, Glazer, Evan S

“…Centralized care for patients with pancreatic cancer is associated with longer survival. We hypothesized that increased travel distance from home is associated…”
Get more information

Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression by Hussain, S. Mazher, Kansal, Rita G., Alvarez, Marcus A., Hollingsworth, T. J., Elahi, Abul, Miranda-Carboni, Gustavo, Hendrick, Leah E., Pingili, Ajeeth K., Albritton, Lorraine M., Dickson, Paxton V., Deneve, Jeremiah L., Yakoub, Danny, Hayes, D. Neil, Kurosu, Michio, Shibata, David, Makowski, Liza, Glazer, Evan S.

“…Purpose The transforming growth factor-beta (TGF-β) pathway plays a paradoxical, context-dependent role in pancreatic ductal adenocarcinoma (PDAC): a…”
Get full text

Abstract C18: TGF-beta blockade paradoxically activates non-SMAD signaling by Husain, S. Mazher, Kansal, Rita, Alvarez, Marcus A., Glazer, Evan S.

“…Transforming growth factor-beta (TGF-B) activates a receptor leading to a critical signaling cascade in pancreatic ductal adenocarcinoma (PDAC) that results in…”
Get full text

Mo1124 – TGF-β Treatment is Associated with a Decrease in Metastatic Potential But Inceased C-Myc Expression in Pancreatic Adenocarcinoma Cell Lines by Alvarez, Marcus A., Li, Yongchao, Hussain, Syed M., Glazer, Evan S.

Get full text

890 TGF-β RECEPTOR INHIBITION INCREASES PD-L1 EXPRESSION IN PANCREATIC CANCER by Alvarez, Marcus A., Hussain, Syed M., Kansal, Rita G., Hendrick, Leah, Dickson, Paxton, Deneve, Jeremiah, Shibata, David, Glazer, Evan S.

Get full text

The effect of TGF-β on PD-L1 expression on PDAC TAMs by Trebska-McGowan, Katarzyna, Makowski, Liza, Alvarez, Marcus A., Kansal, Rita, Husain, S. Mazher, Pingili, Ajeeth K., Glazer, Evan Scott

“…Abstract only 764 Background: Pancreatic Ductal Adenocarcinoma (PDAC) has less than a 10% five year survival and will become the second leading cause of US…”
Get full text

Abstract 2374: Non-canonical TGF-beta signaling modulates pancreatic ductal adenocarcinoma progression by Hussain, S. Mazher, Miranda-Carboni, Gustavo, Alvarez, Marcus A., Elahi, Abul, Hedrick, Leah E., Shibata, David, Glazer, Evan S.

“…Introduction: While the genomic and proteomic characterization of pancreatic ductal adenocarcinoma (PDAC) is extraordinarily complex, the transforming growth…”
Get full text

High-income is a stronger predictor than race in understanding disparate survival outcomes in PDAC by Alvarez, Marcus A, Deneve, Jeremiah Lee, Behrman, Stephen W, Dickson, Paxton Vandiver, Shibata, David, Glazer, Evan Scott

“…Abstract only 241 Background: Patients with pancreatic ductal adenocarcinoma (PDAC) from low income and minority racial groups have a lower reported long-term…”
Get full text

Chemoresistance in Pancreatic Carcinoma Induces PD-L1 and CD44 Expression by Alvarez, Marcus A., Kansal, Rita S., Hussain, Mazher S., Dickson, Paxton V., Deneve, Jeremiah L., Yakoub, Danny, Shibata, David, Glazer, Evan S.

Get full text